Syngene International Limited (NSE:SYNGENE)
India · Delayed Price · Currency is INR 383.10
-0.90 (-0.23%)
Sep 11, 2026, 3:29 PM IST
Syngene International Market Cap
Syngene International has a market cap or net worth of 152.33 billion as of September 11, 2026. Its market cap has decreased by -41.36% in one year.
Market Cap
152.33B
Enterprise Value
144.03B
Revenue
36.00B
Ranking
n/a
PE Ratio
69.99
Stock Price
383.10
ChartMarket Cap Chart
Since August 11, 2015, Syngene International's market cap has increased from 62.11B to 152.33B, an increase of 145.26%. That is a compound annual growth rate of 8.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 152.33B | -41.22% |
| Dec 31, 2025 | 259.16B | -24.09% |
| Dec 31, 2024 | 341.40B | 22.54% |
| Dec 29, 2023 | 278.60B | 19.79% |
| Dec 30, 2022 | 232.57B | -5.39% |
| Dec 31, 2021 | 245.81B | -3.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.41T |
| Divi's Laboratories | 2.47T |
| Apollo Hospitals Enterprise | 1.27T |
| Lenskart Solutions | 1.19T |
| Dr. Agarwal's Health Care | 161.15B |
| Alembic Pharmaceuticals | 159.40B |
| Concord Biotech | 157.52B |
| Vijaya Diagnostic Centre | 154.55B |